![](https://www.statnews.com/wp-content/uploads/2024/04/Siedziba_Boehringer_Ingelheim_w_Polsce-1024x576.jpeg)
STAT+: Judge rules against Boehringer Ingelheim in pharma’s latest legal loss on Medicare negotiation
WASHINGTON — A federal judge ruled against Boehringer Ingelheim’s challenge to the new Medicare drug price negotiation program, handing the pharmaceutical industry its latest in a string of legal losses. The company had argued before the U.S. District …